cleanenergysolutions.jpg

Tecogen Announces
Second Quarter 2024 Results

NORTH BILLERICA, Mass., August 7, 2024 - Tecogen Inc. (OTCQX:TGEN), a leading manufacturer of clean energy products, reported revenues of $4.7 million and net loss of $1.5 million for the quarter ended June 30, 2024 compared to revenues of $6.7 million, and a net loss of $0.8 million in 2023. We generated $0.1 million in cash from operations during the six months ended June 30, 2024 and our cash balance was $0.8 million at June 30, 2024.
“As expected, during Q2 we had no production as we moved our factory and offices. Now, I believe we are about to put the challenges of the last year and half behind us.

We've found new markets for our products despite anti-fossil fuel laws in New York City, Boston, and other east coast regions. We've successfully managed the $675k factory move without a dilutive equity raise.

Customers have told us to expect substantial product orders before the end of Q3. Some of these are in regions that are receptive to natural gas. Some are in new segments like data centers. During the investor call, I will discuss why our technology is better than the alternatives for data centers. I'll also explain how collocation and enterprise data centers have unique needs that our products can solve," commented Abinand Rangesh, Tecogen's Chief Executive Officer.

Key Takeaways
Net Loss and Earnings Per Share
Net loss for the three months ended June 30, 2024 was $1.54 million compared to a net loss of $0.78 million for the same period of 2023, an increase of $0.76 million, due to decreased revenue and gross profit for our Products segment due to the relocation of our manufacturing operations to our new facility in April 2024. EPS for the three months ended June 30, 2024 and 2023 was $(0.06)/share and $(0.03)/share, respectively.
Net loss for the six months ended June 30, 2024 was $2.64 million compared to a net loss of $2.27 million in 2023, an increase of $0.37 million, due to decreased revenue and gross profit for our Products segment due to the relocation of our manufacturing operations to our new facility in April 2024. EPS for the six months ended June 30, 2024 and 2023 was $(0.11)/share and $(0.09)/share, respectively.























Loss from Operations
Loss from operations for the three months ended June 30, 2024 was $1.47 million compared to a loss from operations of $0.78 million for the same period in 2023, an increase of $0.69 million, due to decreased revenue and gross profit for our Products segment.
Loss from operations for the six months ended June 30, 2024 was $2.5 million compared to a loss from operations of $2.2 million for the same period in 2023, an increase of $0.3 million, due to decreased revenue and gross profit for our Products segment.
Revenues
Revenues for the three months ended June 30, 2024 were $4.7 million compared to $6.7 million for the same period in 2023, a 29.9% decrease.
Products revenues in the three months ended June 30, 2024 were $120 thousand compared to $2.4 million for the same period in 2023, a decrease of 95.1%. The decrease in revenue during the three months ended June 30, 2024 is due to the relocation of our manufacturing operations to our new facility in April 2024, which necessitated construction activities to install equipment test cells and comply with local regulations, significantly reducing our production capacity. We plan to resume manufacturing operations during the third quarter of 2024.
Service revenues in the three months ended June 30, 2024 were $4.1 million, compared to $4.0 million for the same period in 2023, an increase of 4.4% due to increased in revenue from the acquired Aegis maintenance contracts and increased revenues from existing contracts
Energy Production revenues in the three months ended June 30, 2024 were $482 thousand compared to $350 thousand for the same period in 2023, an increase of 37.5%. The increase in Energy Production revenue is due to increased run hours at certain energy production sites.

Revenues for the six months ended June 30, 2024 were $10.9 million compared to $12.1 million for the same period in 2023, a decrease of 10.0% year over year.
Products revenues in the six months ended June 30, 2024 were $1.6 million compared to $4.2 million for the same period in 2023, a decrease of 61.2%. The decrease in revenue during the six months ended June 30, 2024 is due to the relocation of our manufacturing operations to our new facility in April 2024, which necessitated construction activities to install equipment test cells and comply with local regulations, significantly reducing our production capacity. We plan to resume manufacturing operations during the third quarter of 2024.
Service revenues in the six months ended June 30, 2024 were $8.1 million compared to $7.1 million for the same period in 2023, an increase of 14.8%. The increase in revenue during the six months ended June 30, 2024 is due to the addition of $0.8 million in revenue from the acquired Aegis maintenance contracts, and a $0.2 million increase in service contract revenues from existing contracts.
Energy Production revenues in the six months ended June 30, 2024 were $1.2 million, compared to $0.9 million for the same period in 2023, an increase of 31.5%. The increase in Energy Production revenue is due to increased run hours at certain energy production sites.





















Gross Profit
Gross profit for the three months ended June 30, 2024 was $2.1 million compared to $2.8 million in the same period in of 2023. Gross margin increased to 44.0% in the three months ended June 30, 2024 compared to 42.0% for the same period in 2023. The increase in gross profit margin was driven by increased Service contract revenues and improved Energy Production gross profit due to higher revenues and lower costs.
Gross profit for the six months ended June 30, 2024 was $4.7 million compared to $4.9 million in the same period of 2023. Gross margin increased to 42.7% in the first quarter compared to 40.6% for the same period in 2023. The increase in gross profit margin was driven by increased Service contract revenues.

Operating Expenses

Operating expenses decreased $62 thousand, or 1.7%, to $3.55 million in the three months ended June 30, 2024 compared to $3.61 million in the same period in 2023.
Operating expenses increased $22 thousand, or 0.3%, to $7.18 million in the six months ended June 30, 2024 compared to $7.16 million in the same period in 2023.

Adjusted EBITDA(1) was negative $1.3 million for the three months ended June 30, 2024 compared to negative $0.6 million for the three months ended June 30, 2023. Adjusted EBITDA(1) was negative $2.2 million for the six months ended June 30, 2024 compared to negative $1.9 million for the six months ended June 30, 2023. (Adjusted EBITDA is defined as net income or loss attributable to Tecogen, adjusted for interest, income taxes, depreciation and amortization, stock-based compensation expense, unrealized gain or loss on investment securities, goodwill impairment charges and other non-cash non-recurring charges or gains including abandonment of intangible assets. See the table following the Condensed Consolidated Statements of Operations for a reconciliation from net income (loss) to Adjusted EBITDA, as well as important disclosures about the company's use of Adjusted EBITDA).
Conference Call Scheduled for August 8, 2024, at 9:30 am ET
Tecogen will host a conference call on August 8, 2024 to discuss the second quarter results beginning at 9:30 am eastern time. To listen to the call please dial (800) 715-9871 within the U.S. and Canada, or (646) 307-1963 from other international locations. Participants should ask to be joined to the Tecogen Second Quarter 2024 earnings call. Please begin dialing 10 minutes before the scheduled starting time. The earnings press release will be available on the Company website at www.Tecogen.com in the "News and Events" section under "About Us." The earnings conference call will be webcast live. To view the associated slides, register for and listen to the webcast, go to https://ir.tecogen.com/ir-calendar. Following the call, the recording will be archived for 14 days.
The earnings conference call will be recorded and available for playback one hour after the end of the call. To listen to the playback, dial (877) 660-6853 within the U.S. and Canada, or (201) 612-7415 from other international locations and use Conference Call ID#: 13672659.





















About Tecogen
Tecogen Inc. designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company provides cost effective, environmentally friendly and reliable products for energy production that nearly eliminate criteria pollutants and significantly reduce a customer’s carbon footprint.
In business for over 35 years, Tecogen has shipped more than 3,200 units, supported by an established network of engineering, sales, and service personnel across the United States. For more information, please visit www.tecogen.com or contact us for a free Site Assessment.
Tecogen, InVerde e+, Tecochill, Tecopower, Tecofrost, Tecopack, and Ultera are registered trademarks of Tecogen Inc.
Forward Looking Statements

This press release and any accompanying documents, contain “forward-looking statements” which may describe strategies, goals, outlooks or other non-historical matters, or projected revenues, income, returns or other financial measures, that may include words such as "believe," "expect," "anticipate," "intend," "plan,"  "estimate," "project," "target," "potential," "will," "should," "could," "likely," or "may" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements.

In addition to those factors described in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and on our Form 8-K, under “Risk Factors”, among the factors that could cause actual results to differ materially from past and projected future results are the following: fluctuations in demand for our products and services, competing technological developments, issues relating to research and development, the availability of incentives, rebates, and tax benefits relating to our products and services, changes in the regulatory environment relating to our products and services, integration of acquired business operations, and the ability to obtain financing on favorable terms to fund existing operations and anticipated growth.

In addition to GAAP financial measures, this press release includes certain non-GAAP financial measures, including adjusted EBITDA which excludes certain expenses as described in the presentation. We use Adjusted EBITDA as an internal measure of business operating performance and believe that the presentation of non-GAAP financial measures provides a meaningful perspective of the underlying operating performance of our current business and enables investors to better understand and evaluate our historical and prospective operating performance by eliminating items that vary from period to period without correlation to our core operating performance and highlights trends in our business that may not otherwise be apparent when relying solely on GAAP financial measures.




















Tecogen Media & Investor Relations Contact Information:

Abinand Rangesh
P: 781-466-6487
E: Abinand.Rangesh@tecogen.com





















TECOGEN INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited)
June 30, 2024December 31, 2023
ASSETS
Current assets:
Cash and cash equivalents$841,913 $1,351,270 
Accounts receivable, net5,364,228 6,781,484 
Unbilled revenue1,258,532 1,258,532 
Inventories, net10,113,493 10,553,419 
Prepaid and other current assets486,424 360,639 
Total current assets18,064,590 20,305,344 
Long-term assets:
Property, plant and equipment, net1,503,204 1,162,577 
Right of use assets2,176,953 943,283 
Intangible assets, net2,698,656 2,436,230 
Goodwill2,563,862 2,743,424 
Other assets147,695 201,771 
TOTAL ASSETS$27,154,960 $27,792,629 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Related party notes$518,305 $505,505 
Accounts payable4,405,769 4,514,415 
Accrued expenses2,544,467 2,504,629 
Deferred revenue, current2,558,799 1,647,206 
Lease obligations, current475,253 289,473 
Acquisition liabilities, current859,619 845,363 
Unfavorable contract liability, current147,643 176,207 
Total current liabilities11,509,855 10,482,798 
Long-term liabilities:
Deferred revenue, net of current portion264,284 369,611 
Lease obligations, net of current portion1,703,543 683,307 
Acquisition liabilities, net of current portion1,222,690 1,181,779 
Unfavorable contract liability, net of current portion359,041 422,839 
Total liabilities15,059,413 13,140,334 
Stockholders’ equity:
Common stock, $0.001 par value; 100,000,000 shares authorized; 24,850,261 issued and outstanding at June 30, 2024 and December 31, 202324,850 24,850 
Additional paid-in capital57,691,400 57,601,402 
Accumulated deficit(45,523,419)(42,879,656)
Total Tecogen Inc. stockholders’ equity12,192,831 14,746,596 
Non-controlling interest(97,284)(94,301)
Total stockholders’ equity12,095,547 14,652,295 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$27,154,960 $27,792,629 























TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
Three Months Ended
 June 30, 2024June 30, 2023
Revenues
Products$119,673 $2,445,631 
Services4,126,517 3,952,971 
Energy production481,597 350,156 
Total revenues4,727,787 6,748,758 
Cost of sales
Products171,982 1,618,456 
Services2,191,815 2,075,869 
Energy production284,835 220,007 
Total cost of sales2,648,632 3,914,332 
Gross profit2,079,155 2,834,426 
Operating expenses
General and administrative2,897,993 2,917,283 
Selling405,277 480,786 
Research and Development246,489 236,556 
(Gain) loss on disposition of assets3,363 (19,950)
Total operating expenses3,553,122 3,614,675 
Loss from operations(1,473,967)(780,249)
Other income (expense)
Other income (expense), net18,894 (21,061)
Interest expense(17,869)(1,857)
Unrealized gain (loss) on investment securities(37,497)37,497 
Total other income (expense), net(36,472)14,579 
Loss before income taxes(1,510,439)(765,670)
Provision for state income taxes37 9,614 
Consolidated net loss(1,510,476)(775,284)
Income attributable to the non-controlling interest(28,320)(4,826)
Net loss attributable to Tecogen Inc.$(1,538,796)$(780,110)
Net loss per share - basic$(0.06)$(0.03)
Net loss per share - diluted$(0.06)$(0.03)
Weighted average shares outstanding - basic24,850,261 24,850,261 
Weighted average shares outstanding - diluted24,850,261 24,850,261 





















Three Months Ended
June 30, 2024June 30, 2023
Non-GAAP financial disclosure (1)
Net loss attributable to Tecogen Inc.$(1,538,796)$(780,110)
Interest expense, net17,869 1,857 
Income taxes37 9,614 
Depreciation & amortization, net141,137 185,175 
EBITDA(1,379,753)(583,464)
Stock based compensation45,463 28,589 
Unrealized loss (gain) on investment securities37,497 (37,497)
Adjusted EBITDA$(1,296,793)$(592,372)



















































TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
Six Months Ended
June 30, 2024June 30, 2023
Revenues
Products$1,611,071 $4,155,767 
Services8,140,827 7,089,144 
Energy production1,161,985 883,665 
Total revenues10,913,883 12,128,576 
Cost of sales
Products1,221,525 2,831,024 
Services4,284,072 3,813,471 
Energy production753,475 557,746 
Total cost of sales6,259,072 7,202,241 
Gross profit4,654,811 4,926,335 
Operating expenses
General and administrative5,746,559 5,709,766 
Selling934,946 1,000,856 
Research and development501,185 465,658 
Gain on sale of assets(4,028)(19,950)
Total operating expenses7,178,662 7,156,330 
Loss from operations(2,523,851)(2,229,995)
Other income (expense)
Interest and other income (expense), net3,147 (20,231)
Interest expense(36,539)(2,272)
Unrealized gain (loss) on investment securities(18,749)37,497 
Total other income (expense), net(52,141)14,994 
Loss before provision for state income taxes(2,575,992)(2,215,001)
Provision for state income taxes22,100 32,252 
Consolidated net loss(2,598,092)(2,247,253)
Income attributable to non-controlling interest(45,671)(22,886)
Net loss attributable to Tecogen Inc.$(2,643,763)$(2,270,139)
Net income loss per share - basic $(0.11)$(0.09)
Net income loss per share - diluted$(0.11)$(0.09)
Weighted average shares outstanding - basic24,850,261 24,850,261 
Weighted average shares outstanding - diluted24,850,261 24,850,261 

























Six Months Ended
June 30, 2024June 30, 2023
Non-GAAP financial disclosure (1)
Net income (loss) attributable to Tecogen Inc.$(2,643,763)$(2,270,139)
Interest & other expense, net33,392 22,503 
Income taxes22,100 32,252 
Depreciation & amortization, net281,498 291,095 
EBITDA(2,306,773)(1,924,289)
Stock based compensation89,998 105,937 
Unrealized (gain) loss on marketable securities18,749 (37,497)
Adjusted EBITDA $(2,198,026)$(1,855,849)

(1) Non-GAAP Financial Measures
In addition to reporting net income, a U.S. generally accepted accounting principle (“GAAP”) measure, this news release contains information about Adjusted EBITDA (net income (loss) attributable to Tecogen Inc adjusted for interest, income taxes, depreciation and amortization, stock-based compensation expense, unrealized gain or loss on investment securities, goodwill impairment charges and other non-cash non-recurring charges including abandonment of certain intangible assets), which is a non-GAAP measure.  The Company believes Adjusted EBITDA allows investors to view its performance in a manner similar to the methods used by management and provides additional insight into its operating results.  Adjusted EBITDA is not calculated through the application of GAAP.  Accordingly, it should not be considered as a substitute for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure.  The use of any non-GAAP measure may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies.




















TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
Six Months Ended
June 30, 2024June 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Consolidated net loss$(2,598,092)(2,247,253)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization281,498 291,095 
Provision for credit losses19,063 44,000 
Stock-based compensation89,998 105,937 
Unrealized (gain) loss on investment securities18,749 (37,497)
Gain on disposition of assets(4,028)(19,950)
Non-cash interest expense12,800 — 
Changes in operating assets and liabilities
(Increase) decrease in:
Accounts receivable1,398,193 755,831 
Employee retention credit— 667,121 
Unbilled revenue— 56,994 
Prepaid assets and other current assets(125,784)(66,201)
Other assets576,926 325,688 
Increase (decrease) in:
Accounts payable(108,646)839,784 
Accrued expenses and other current liabilities39,838 178,241 
Deferred revenue 806,266 752,873 
Other liabilities(756,410)(359,369)
Net cash provided by operating activities90,297 153,676 
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment(556,636)(19,607)
Proceeds from disposition of assets36,213 16,863 
Payment for business acquisition— (170,000)
Distributions to non-controlling interest(48,654)(23,838)
Net cash used in investing activities(569,077)(196,582)
CASH FLOWS FROM FINANCING ACTIVITIES:
Finance lease principal payments(30,577)— 
Net cash used in financing activities(30,577)— 
Net increase in cash and cash equivalents(509,357)(42,906)
Cash and cash equivalents, beginning of the period$1,351,270 1,913,969 
Cash and cash equivalents, end of the period$841,913 $1,871,063 
Supplemental disclosures of cash flows information:
Cash paid for interest$22,909 $1,443 
Cash paid for taxes$22,100 $32,252 
Non-cash investing activities:
Aegis Contract and Related Asset Acquisition:
Accounts receivable credit$— $300,000 
Accounts payable assumed— 111,178 
Contingent consideration272,901 $1,442,462 
Total$272,901 $1,853,640